Medicinal Products

Seroquel XR 400 mg tablete s produljenim oslobađanjem

Name Seroquel XR 400 mg tablete s produljenim oslobađanjem
Marketing Authorisation Number HR-H-789589749
Active Substance kvetiapinfumarat
Composition jedna tableta s produljenim oslobađanjem sadrži 400 mg kvetiapina (u obliku kvetiapinfumarata)
Pharmaceutical Form tableta s produljenim oslobađanjem
Packaging [MA Number for Packaging] 10 tableta u blisteru, u kutiji  [HR-H-789589749-01]
30 tableta u blisteru, u kutiji  [HR-H-789589749-02]
50 tableta u blisteru, u kutiji  [HR-H-789589749-03]
60 tableta u blisteru, u kutiji  [HR-H-789589749-04]
100 tableta u blisteru, u kutiji  [HR-H-789589749-05]
Manufacturer AstraZeneca UK Limited, Macclesfield, Cheshire, Ujedinjeno Kraljevstvo
AstraZeneca GmbH, Wedel, Njemačka
Marketing Authorisation Holder AstraZeneca d.o.o., Radnička cesta 80, Zagreb, Hrvatska
Marketing Authorisation Date 20.04.2016
MA Period of Validity unlimited
Classification Number UP/I-530-09/15-02/72
Registration Number 381-12-01/70-16-07
Prescription na recept
Type of prescription ponovljivi recept
Distribution u ljekarni
Advertising to general public zabranjeno
ATC Code N05AH04
Medicinal product marketed in the Croatia Da
SmPC download
PL download
Public Assessment Report download
Educational materials
for healthcare professionals
Podsjetnik o važnosti nadziranja metaboličkih parametara tijekom liječenja kvetiapinom, verzija 2
Back